LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-20,45 % | 10,82 Mrd. | |
+43,17 % | 3,25 Mrd. | |
-35,86 % | 2,11 Mrd. | |
-17,21 % | 2,08 Mrd. | |
-29,81 % | 1,48 Mrd. | |
+17,56 % | 1,02 Mrd. | |
-4,37 % | 733 Mio. | |
-37,00 % | 391 Mio. | |
-46,94 % | 383 Mio. |